METASTATIC LUNG CANCER
Clinical trials for METASTATIC LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to outsmart lung cancer resistance
Disease control Not yet recruitingThis study tests two experimental drugs, ANS014004 and PLB1004, given together to people with a specific type of advanced lung cancer (EGFR mutation-positive NSCLC). The goal is to find a safe dose and see if the combination can shrink tumors or stop them from growing, especially…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Morning or afternoon? new study tests if immunotherapy timing boosts cancer fight
Knowledge-focused Not yet recruitingThis study looks at whether getting immunotherapy infusions in the morning versus the afternoon changes outcomes for people with advanced lung cancer or head and neck cancer. About 238 participants will be randomly assigned to morning or afternoon infusions. Researchers will trac…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC